These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25324949)

  • 21. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.
    Samarinas M; Dimitropoulos K; Zachos I; Gravas S; Karatzas A; Tzortzis V
    World J Urol; 2016 Nov; 34(11):1555-1559. PubMed ID: 26951136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones.
    AlKhateeb SS; AlShammari NA; AlZughaibi MA; Ghazwani YG; Alrabeeah KA; Albqami NM
    Saudi Med J; 2016 Aug; 37(8):860-3. PubMed ID: 27464862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.
    Hwang EC; Jung SI; Seo YH; Jeong SH; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2015 Apr; 47(4):595-601. PubMed ID: 25712677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
    Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
    World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    Seitz M; Stief C; Waidelich R; Bader M; Tilki D
    World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.
    Chambó RC; Tsuji FH; Yamamoto HA; Jesus CM
    Int Braz J Urol; 2015; 41(1):46-56. PubMed ID: 25928510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious complications following transrectal ultrasound-guided prostate biopsy: a Canadian tertiary cancer center experience.
    Al-Busaidi I; Leis JA; Gold WL; McGeer A; Toi A
    Infect Control Hosp Epidemiol; 2015 May; 36(5):614-6. PubMed ID: 25703214
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high.
    Kim DH; Bae SR; Choi WS; Park HK; Paick SH; Kim HG; Loh YS
    Korean J Urol; 2014 Sep; 55(9):593-8. PubMed ID: 25237461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
    Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K
    Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive urine culture prior to transrectal prostate biopsy was not associated with infectious complications development.
    Mrad Dali K; Rahoui M; Chaker K; Ouanes Y; Bibi M; Sellami A; Ben Rhouma S; Nouira Y
    Prog Urol; 2022 Oct; 32(12):830-835. PubMed ID: 35787977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on techniques to prevent infections associated with prostate needle biopsy.
    Fontana M; Boeri L; Montanari E
    Curr Opin Urol; 2018 Jul; 28(4):392-397. PubMed ID: 29697470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stemming the Tide: Infectious Complications After Prostate Biopsy.
    Black P
    World J Urol; 2015 Jun; 33(6):893, 896-7. PubMed ID: 25985751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.